Chapter 5.5 Transgenic mouse models of Alzheimer's disease and episodic-like memory

David R. Borchelt, Alena Savonenko

Research output: Contribution to journalArticle

Abstract

In this chapter, we discuss examples of behavioral studies of several transgenic models of Alzheimer's-type amyloidosis, providing examples of approaches and comparisons of outcomes for reference, episodic-like, and working memory. Most studies have attempted to link changes in the levels of Aβ peptides (the primary component of senile plaques in Alzheimer's disease) to the onset of deficits in one type of memory, focusing on one behavioral task to assess specific cognitive functions. Studies that have analyzed concurrent changes in different memory systems have shown that tasks requiring flexible use of information "what," "where," and/or "when" (the episodic-like memory tasks) are useful in detecting losses in memory function. In general, impairments in episodic-like memory were detected earlier than in reference memory and were highly correlated with amyloid plaque load. An analysis of the literature, including our own studies, indicates that the accumulation of Aβ peptides impacts the cognitive functions of mice differentially as a function of age and Aβ amyloid load. Cognitive decline appears to be gradually progressive with parallels to human patients in that episodic-like memory is the first memory system affected. More importantly, the physical form of Aβ peptide (monomer, soluble oligomer, or fibril) that mediates memory deficits may differ at various stages of the disease, a finding that could alter strategies for treatment for this disease.

Original languageEnglish (US)
Pages (from-to)553-573
Number of pages21
JournalHandbook of Behavioral Neuroscience
Volume18
DOIs
StatePublished - 2008

Fingerprint

Episodic Memory
Transgenic Mice
Alzheimer Disease
Amyloid Plaques
Memory Disorders
Cognition
Peptides
Amyloidosis
Short-Term Memory
Amyloid
Therapeutics

Keywords

  • Aβ amyloid plaques
  • episodic-like memory
  • progression of memory deficits
  • reference memory
  • working memory

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Cognitive Neuroscience

Cite this

Chapter 5.5 Transgenic mouse models of Alzheimer's disease and episodic-like memory. / Borchelt, David R.; Savonenko, Alena.

In: Handbook of Behavioral Neuroscience, Vol. 18, 2008, p. 553-573.

Research output: Contribution to journalArticle

@article{33369469cf974807894c80910572cb36,
title = "Chapter 5.5 Transgenic mouse models of Alzheimer's disease and episodic-like memory",
abstract = "In this chapter, we discuss examples of behavioral studies of several transgenic models of Alzheimer's-type amyloidosis, providing examples of approaches and comparisons of outcomes for reference, episodic-like, and working memory. Most studies have attempted to link changes in the levels of Aβ peptides (the primary component of senile plaques in Alzheimer's disease) to the onset of deficits in one type of memory, focusing on one behavioral task to assess specific cognitive functions. Studies that have analyzed concurrent changes in different memory systems have shown that tasks requiring flexible use of information {"}what,{"} {"}where,{"} and/or {"}when{"} (the episodic-like memory tasks) are useful in detecting losses in memory function. In general, impairments in episodic-like memory were detected earlier than in reference memory and were highly correlated with amyloid plaque load. An analysis of the literature, including our own studies, indicates that the accumulation of Aβ peptides impacts the cognitive functions of mice differentially as a function of age and Aβ amyloid load. Cognitive decline appears to be gradually progressive with parallels to human patients in that episodic-like memory is the first memory system affected. More importantly, the physical form of Aβ peptide (monomer, soluble oligomer, or fibril) that mediates memory deficits may differ at various stages of the disease, a finding that could alter strategies for treatment for this disease.",
keywords = "Aβ amyloid plaques, episodic-like memory, progression of memory deficits, reference memory, working memory",
author = "Borchelt, {David R.} and Alena Savonenko",
year = "2008",
doi = "10.1016/S1569-7339(08)00230-0",
language = "English (US)",
volume = "18",
pages = "553--573",
journal = "Handbook of Behavioral Neuroscience",
issn = "1569-7339",
publisher = "Elsevier",

}

TY - JOUR

T1 - Chapter 5.5 Transgenic mouse models of Alzheimer's disease and episodic-like memory

AU - Borchelt, David R.

AU - Savonenko, Alena

PY - 2008

Y1 - 2008

N2 - In this chapter, we discuss examples of behavioral studies of several transgenic models of Alzheimer's-type amyloidosis, providing examples of approaches and comparisons of outcomes for reference, episodic-like, and working memory. Most studies have attempted to link changes in the levels of Aβ peptides (the primary component of senile plaques in Alzheimer's disease) to the onset of deficits in one type of memory, focusing on one behavioral task to assess specific cognitive functions. Studies that have analyzed concurrent changes in different memory systems have shown that tasks requiring flexible use of information "what," "where," and/or "when" (the episodic-like memory tasks) are useful in detecting losses in memory function. In general, impairments in episodic-like memory were detected earlier than in reference memory and were highly correlated with amyloid plaque load. An analysis of the literature, including our own studies, indicates that the accumulation of Aβ peptides impacts the cognitive functions of mice differentially as a function of age and Aβ amyloid load. Cognitive decline appears to be gradually progressive with parallels to human patients in that episodic-like memory is the first memory system affected. More importantly, the physical form of Aβ peptide (monomer, soluble oligomer, or fibril) that mediates memory deficits may differ at various stages of the disease, a finding that could alter strategies for treatment for this disease.

AB - In this chapter, we discuss examples of behavioral studies of several transgenic models of Alzheimer's-type amyloidosis, providing examples of approaches and comparisons of outcomes for reference, episodic-like, and working memory. Most studies have attempted to link changes in the levels of Aβ peptides (the primary component of senile plaques in Alzheimer's disease) to the onset of deficits in one type of memory, focusing on one behavioral task to assess specific cognitive functions. Studies that have analyzed concurrent changes in different memory systems have shown that tasks requiring flexible use of information "what," "where," and/or "when" (the episodic-like memory tasks) are useful in detecting losses in memory function. In general, impairments in episodic-like memory were detected earlier than in reference memory and were highly correlated with amyloid plaque load. An analysis of the literature, including our own studies, indicates that the accumulation of Aβ peptides impacts the cognitive functions of mice differentially as a function of age and Aβ amyloid load. Cognitive decline appears to be gradually progressive with parallels to human patients in that episodic-like memory is the first memory system affected. More importantly, the physical form of Aβ peptide (monomer, soluble oligomer, or fibril) that mediates memory deficits may differ at various stages of the disease, a finding that could alter strategies for treatment for this disease.

KW - Aβ amyloid plaques

KW - episodic-like memory

KW - progression of memory deficits

KW - reference memory

KW - working memory

UR - http://www.scopus.com/inward/record.url?scp=67649757582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649757582&partnerID=8YFLogxK

U2 - 10.1016/S1569-7339(08)00230-0

DO - 10.1016/S1569-7339(08)00230-0

M3 - Article

VL - 18

SP - 553

EP - 573

JO - Handbook of Behavioral Neuroscience

JF - Handbook of Behavioral Neuroscience

SN - 1569-7339

ER -